Biotech | May 09, 2022
ExoCoBio receives Japanese patent for alleviating dermatitis
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
The new facility is scheduled to start operation in the first half of 2024
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The plant is scheduled to come on stream in September 2024
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
Subscribe To Our Newsletter & Stay Updated
